Editorial
Immunotherapy, cancer and rheumatic diseases
Inmunoterapia, cáncer y enfermedades reumatológicas
Read
5894
Timeswas read the article
2064
Total PDF
3830
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 4 | 2 | 6 |
| 2025 5 | 127 | 46 | 173 |
| 2025 4 | 96 | 31 | 127 |
| 2025 3 | 103 | 30 | 133 |
| 2025 2 | 99 | 47 | 146 |
| 2025 1 | 88 | 49 | 137 |
| 2024 12 | 60 | 48 | 108 |
| 2024 11 | 55 | 61 | 116 |
| 2024 10 | 37 | 39 | 76 |
| 2024 9 | 43 | 35 | 78 |
| 2024 8 | 80 | 60 | 140 |
| 2024 7 | 67 | 42 | 109 |
| 2024 6 | 67 | 42 | 109 |
| 2024 5 | 76 | 28 | 104 |
| 2024 4 | 69 | 29 | 98 |
| 2024 3 | 60 | 29 | 89 |
| 2024 2 | 63 | 35 | 98 |
| 2024 1 | 55 | 24 | 79 |
| 2023 12 | 47 | 26 | 73 |
| 2023 11 | 48 | 30 | 78 |
| 2023 10 | 47 | 36 | 83 |
| 2023 9 | 106 | 49 | 155 |
| 2023 8 | 97 | 14 | 111 |
| 2023 7 | 58 | 23 | 81 |
| 2023 6 | 48 | 27 | 75 |
| 2023 5 | 65 | 21 | 86 |
| 2023 4 | 40 | 12 | 52 |
| 2023 3 | 83 | 24 | 107 |
| 2023 2 | 66 | 29 | 95 |
| 2023 1 | 77 | 17 | 94 |
| 2022 12 | 105 | 24 | 129 |
| 2022 11 | 72 | 34 | 106 |
| 2022 10 | 81 | 37 | 118 |
| 2022 9 | 59 | 24 | 83 |
| 2022 8 | 59 | 51 | 110 |
| 2022 7 | 59 | 50 | 109 |
| 2022 6 | 57 | 39 | 96 |
| 2022 5 | 59 | 43 | 102 |
| 2022 4 | 77 | 35 | 112 |
| 2022 3 | 73 | 48 | 121 |
| 2022 2 | 56 | 35 | 91 |
| 2022 1 | 72 | 40 | 112 |
| 2021 12 | 68 | 44 | 112 |
| 2021 11 | 65 | 49 | 114 |
| 2021 10 | 70 | 41 | 111 |
| 2021 9 | 43 | 39 | 82 |
| 2021 8 | 32 | 32 | 64 |
| 2021 7 | 33 | 18 | 51 |
| 2021 6 | 42 | 32 | 74 |
| 2021 5 | 50 | 49 | 99 |
| 2021 4 | 128 | 92 | 220 |
| 2021 3 | 75 | 32 | 107 |
| 2021 2 | 55 | 23 | 78 |
| 2021 1 | 53 | 23 | 76 |
| 2020 12 | 53 | 22 | 75 |
| 2020 11 | 44 | 18 | 62 |
| 2020 10 | 29 | 17 | 46 |
| 2020 9 | 31 | 13 | 44 |
| 2020 8 | 29 | 23 | 52 |
| 2020 7 | 17 | 15 | 32 |
| 2020 6 | 12 | 14 | 26 |
| 2020 5 | 20 | 12 | 32 |
| 2020 4 | 15 | 9 | 24 |
| 2020 3 | 4 | 2 | 6 |
| 2020 1 | 1 | 0 | 1 |
| 2019 11 | 1 | 0 | 1 |
Show all
